glp-1/gip agonists The Effects of Dual Receptor Agonism on Glucagon Secretion—A Review Dual and Triple Gut Peptide

Gastric inhibitory polypeptide receptor antagonist, SKL-14959, suppressed body weight gain on diet-induced obesity mice

J.AkerstromV.PanW

Accordingly, despite losing 25% of their body mass, GLP-1MK-801-treated mice maintained an energy expenditure that was similar to that of vehicle-treated control mice and was therefore also significantly higher than the gradually decreasing energy expenditure observed in mice that were calorie-restricted to match the weight loss trajectory of GLP-1MK-801-treated mice

2021 Mar 18;384(11):989-1002

Its physiological actions include stimulating glucose-dependent insulin secretion, suppressing glucagon release, delaying gastric emptying, and enhancing satietymechanisms that collectively contribute to glucose lowering and weight reduction

John Barlow has sat on advisory board panels and received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Mylan, Novartis and Sanofi/Aventis